A University of Massachusetts Amherst researcher has received funding from the National Cancer Institute (NCI) to study the complex relationship between drugs used to treat metastatic cancer and the ...
A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract ...
Metastatic patterns plus clinical and molecular characteristics of ROS1 aberrations in non-small cell lung cancer patients without rearrangements. Evaluation of the therapeutic effect on primary lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results